{"name":"Cristal Therapeutics","slug":"cristal-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOTFRHX3RRWnlPdzdtSkdLSUo0dWsxMGFLel9tVmNEcGpKR0IzNXhLM3VpeFlFMTBBbFZxZ0YwUEp3V25HUWE0Y0kxNzhpa1pyakhQbzNaZEE4LVRYTDItd2d5aDBqbjluU1hNa3BtQjFCT2xST1ZabFRwaWg1OTEzMmZBSHA2YTBPbDdxN3JhWUd0cVFRd29oVFdjMTdac3ZZaW1rbHpwOE9jaEFJcVp1NG80aThZUExHd1FKM0VhcGhKM3cxX1FIcHBObEh2T285SmJFQWJTSHpvbUpsT0pQS1VpQ2hWYzJ0eEpwZk91dEo?oc=5","date":"2026-03-27","type":"trial","source":"Barchart.com","summary":"Ovarian Cancer Clinical Trial Pipeline Expands as 180+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com","headline":"Ovarian Cancer Clinical Trial Pipeline Expands as 180+ Companies Driving Innovation in the Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNZng1WlVHNlJXZWJHZnlKUXM0VE52LXJoVFQ1Z3hXWGhxWXNUYmNLeW1rTmcxY3VGRzBpTXBfTDFIN1FLQmxyWXVQaVptUTN5eDJnXzFSc1YwWC1ObFBON25OOUpHWmpPUjU3aWFfaHhiV2hHdFQwTnRUVkhqY0hwTG5ONUcxWE50RWtmc1dFbDh5bHJxN1E?oc=5","date":"2026-02-16","type":"deal","source":"The Motley Fool","summary":"Got $300? 2 Biotech Stocks to Buy and Hold Forever - The Motley Fool","headline":"Got $300? 2 Biotech Stocks to Buy and Hold Forever","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNalMwQkNibUNDcVZFZGNqYm5oWUhjWHc1UnNaTTlJY1ludnJueVVCdl9VVlhIZTZLcER0bDI3RmVLbWl6TEFwUnZrbm96MWVSajhnX0t4VTVIRjliblQ2U1VYODB6UEZybUo2T2ttYnNrVXcwLTAzYTY0OFVBN1p4ZHFOdDgzS1d0b1YteGxpSUZURDVsM3RYN1BHV0pZcnlvN0s4THZxZmx6aE1yVzNDMVd6Q0NnVDRGcGxUR0MwMzg0OW13Nm5BVW5WWkJaTjhveExHTFQxQmVUNDZnRl9WcXoxa0Y3UQ?oc=5","date":"2025-09-30","type":"trial","source":"Reuters","summary":"Crystalys Therapeutics launches with $205 million funding round for trials of gout drug - Reuters","headline":"Crystalys Therapeutics launches with $205 million funding round for trials of gout drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNamtUbFl4NHMwd1ptcFZjSHc5cjVtcjkxT2NaUmdZWGQ2cVd3ZE40bThKTEVleEI4U0pTS1FjUldIcDh3LXJsZk1DVDhjQm1VbVZoTFRraVg1d3RPOTNEeWU3Wm16Y1pvNlFCQm10WlNxdUlndjFFV1MzMkpNVWxleVRicVJERXJIODJzU0FhVV9HWGU0eUZsUEpUQQ?oc=5","date":"2025-09-08","type":"pipeline","source":"The Pharma Letter","summary":"One-shot cures, lasting challenges: gene therapy in 2025 - The Pharma Letter","headline":"One-shot cures, lasting challenges: gene therapy in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOcmlGN2dPTnhtLXBWbXl2UDdrRUthSnk2Z042aVFDUU1VMndyM2drbzFuVXk2R3RSeEdSNXBobTlfM19KNVRWbGZYZjctb0tXaDFrSnFidEFveDROOHhmZFFvbE9SYTNpRm1CMlFJbzI3cGRFa040UlFpNnhqNUhrcFNXUHpqLTA?oc=5","date":"2025-08-21","type":"regulatory","source":"statnews.com","summary":"FDA ‘uncertainty’ forces Krystal Biotech to shutter cancer drug trial - statnews.com","headline":"FDA ‘uncertainty’ forces Krystal Biotech to shutter cancer drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQVWp0ZVJtdUltYlRvRnp2cXQ4MUp6TVh0TlM4WXJrRmw3eThFb1VSN04zM3RlV0xDekx5VzlaLXd3OGg4OWxVZmpWV25uUzJNVzJHTkZHWThKdmU0akVPemhnT1ZWNHE4eXExd0loNnVDaWZlWU9qWlhJaXF2R0l2bG1xM2VNaVV2LVI2T2FnNzRSbWxYSVRMcHZWWQ?oc=5","date":"2025-07-31","type":"pipeline","source":"Forbes","summary":"How A 60-Year-Old Drug Developer Built A $4.4 Billion Biotech Treating ‘Butterfly Skin Disease’ - Forbes","headline":"How A 60-Year-Old Drug Developer Built A $4.4 Billion Biotech Treating ‘Butterfly Skin Disease’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPYWF1OGMwRFNPTm1NQUIwLXZNazhmOUxnOWNBVVU1QmV1THQwQjVKOUZjV2dPSWJvNkhKY1YxeHNMSXo1Z2JfdjZtdU91TkVPV0RXcy1YcU92Q0ZpRUlGemFkX3FBUjlPdlBtTTNfWmZWTHZkRlNuSVVJOUdLWEQ5QzdGNlJRakRJUXFiQUpZbGh1MXlCVENpU2VGZE5xYkU?oc=5","date":"2025-05-14","type":"pipeline","source":"MarketBeat","summary":"Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat","headline":"Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPei1hSnBGUUJON1BmUjl5OWlZUHFxNmxQel9zRXdqb0t6b2cwWXJPcEdZSjBNbG1ZWkVWU3JWVFhfS0l3TWdSX0E2UnNxZ2s0Y0tUTzhON214TFJqTEJoT0FVU2VzZ1NTLWc3NHp1TUV0LW1TYjZ6a0tjbmVNZmRmbi02SU5ndw?oc=5","date":"2025-04-30","type":"pipeline","source":"pharmaphorum","summary":"Abeona prices rare cell disorder gene therapy at $3.1m - pharmaphorum","headline":"Abeona prices rare cell disorder gene therapy at $3.1m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxONXQwdDBFWkdnUnBpNFAyMFNlMzljdXM4RG1Rc2FrVkxZdFo2VEREcXQ0S0JPNzFfck1EWllJNXR3dGxMemJJVnlocEVSbk5WMlJXdXMycDN4YzZ0QUdyS2szQloycVhZeWRjVmw0M1U2UVNwaS1ZZTN1RENMQkpYQ3dhaTg2QnBGLVVPQkV1cTdjc2xZTVl5eC1NZUxDTmctWUtPaHIwX0lscUQ5Q3c?oc=5","date":"2025-04-29","type":"regulatory","source":"BioPharma Dive","summary":"Abeona cell therapy approved by FDA for rare skin condition - BioPharma Dive","headline":"Abeona cell therapy approved by FDA for rare skin condition","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQLXgzRXZMaXVGOGdOS3c0NDRXYTFLa2RydzJrUkIxM1VTOThMYy16c2hSM21JYk8xSVp1U3E5N3VOc19mM0wzU1JrMzRTVW1hdXdadlpieXhvMlV2SWM1WngwUzNadW5FVU8xNTA1aDNPVDlCRU1leTFaWTJCemRVZF9pY3hlVG5CZUE2cFItdzJsS2JpZm5ncnE5cno4NFJ2VTlOcnNMT3p6eW9qdWJBRS1SUDdqNkU4Z0llWmhuRkdrQjdrTHNB?oc=5","date":"2025-04-29","type":"regulatory","source":"Fierce Pharma","summary":"Abeona enters commercial gene therapy arena with FDA nod for Zevaskyn to treat rare genetic skin disease - Fierce Pharma","headline":"Abeona enters commercial gene therapy arena with FDA nod for Zevaskyn to treat rare genetic skin disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOTFWcDVoVDdkWlN2c096eUJSQ0hoN1Q5cG5rN1dVM3VwTy0zZTAtVWo3dTBUOXY0SWdJX2JVZWRGaV90QmNmX1RoRnBBMzhLN0lYcGV5NERRRmZnWVIyY1hPZXJ3SmJPMjJTTWNvc2h1QnZhS0lKWFVaWmJqQUlIeTdPSkNwUkVuLUlyalNnSXRaOHVXOTgyaEFUeDdPWFVhSHNYMVdIUDE4SU9YTU9UaUV2dmxNUHBSc2N6VVUyUnJLQQ?oc=5","date":"2023-05-19","type":"regulatory","source":"Krystal Biotech, Inc","summary":"Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa - Krystal Biotech, Inc","headline":"Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) f","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9HcWdUdEpGVDF5bGxXNjJPSHd1UWtHUXpPNHZfTjcyTjhKVFR2VXM4RTg5bjhFLWNIYzhxaDdONmMyRnJYUzUtMWNYcFBmZ0s0R3NkdmtNZ0g3dllkTlVnc3R5ZTNUY1JDTm9lLThZWnM1Z3lYRWlKQQ?oc=5","date":"2022-06-23","type":"trial","source":"labiotech.eu","summary":"Dutch Cancer Nanoparticles Get €2.5M from the EU to Enter Phase II - labiotech.eu","headline":"Dutch Cancer Nanoparticles Get €2.5M from the EU to Enter Phase II","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}